Merit Medical Systems, Inc. (MMSI)

Merit Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	118.43	120.36	94.41	74.52	48.45	-9.84
Depreciation & Amortization	131.92	114.73	101.29	92.2	95.78	106.82
Other Amortization	6.58	6.77	1.72	0.6	0.6	0.6
Loss (Gain) From Sale of Assets	1.57	1.49	5.41	1.8	1.3	1.64
Asset Writedown & Restructuring Costs	0.21	0.46	1.79	8.45	4.41	30.86
Loss (Gain) From Sale of Investments	-	-	0.27	0.5	-	6
Stock-Based Compensation	43.08	28.47	21.33	18.04	16.09	14.34
Other Operating Activities	-13.63	-14.53	-11.04	-10.42	-1.58	-19.39
Change in Accounts Receivable	-17.8	-13.69	-11.92	-15.12	-8.62	10.43
Change in Inventory	-14.52	-2.29	-32.11	-47.93	-25.18	29.43
Change in Accounts Payable	7.6	-2.31	-7.3	12.66	6.05	0.33
Change in Income Taxes	10.72	-2.41	-1.84	6.05	1.06	-1.16
Change in Other Net Operating Assets	-6.55	-16.25	-16.87	-27.06	8.85	-4.79
Operating Cash Flow	267.61	220.8	145.15	114.29	147.23	165.27
Operating Cash Flow Growth	24.87%	52.12%	27.00%	-22.37%	-10.91%	112.39%
Capital Expenditures	-60.72	-35.14	-34.29	-45.03	-27.94	-45.99
Sale of Property, Plant & Equipment	0.05	0.01	0.2	0.07	1.04	0.04
Cash Acquisitions	-332.83	-320.18	-134.52	-6.88	-7.17	-10.95
Divestitures	0.25	-	0.43	-0.97	-	1.29
Sale (Purchase) of Intangibles	-3.09	-2.9	-2.41	-3.18	-2.83	-3.29
Other Investing Activities	-15.15	-10.43	-4.76	-1.41	-0.25	0.25
Investing Cash Flow	-411.5	-368.65	-175.35	-57.4	-37.16	-58.65
Long-Term Debt Issued	-	-	1,199	215.21	98.42	68.63
Long-Term Debt Repaid	-	-99.06	-579.62	-260.14	-206.92	-157
Net Debt Issued (Repaid)	-23	-99.06	619.58	-44.94	-108.5	-88.38
Issuance of Common Stock	47.66	40.91	15.58	20.07	21.31	6.64
Repurchase of Common Stock	-8.6	-1.59	-5.12	-2.47	-0.58	-0.87
Other Financing Activities	-2.7	-0.26	-70.77	-32.92	-10.67	-13.1
Financing Cash Flow	13.37	-60.01	559.27	-60.26	-98.44	-95.71
Foreign Exchange Rate Adjustments	-0.19	-2.52	-0.48	-3.83	-0.8	1.68
Net Cash Flow	-130.72	-210.38	528.59	-7.19	10.83	12.6
Free Cash Flow	206.88	185.66	110.86	69.26	119.29	119.28
Free Cash Flow Growth	17.88%	67.47%	60.06%	-41.94%	0.01%	-
Free Cash Flow Margin	14.01%	13.69%	8.82%	6.02%	11.10%	12.38%
Free Cash Flow Per Share	3.41	3.13	1.90	1.20	2.08	2.15
Cash Interest Paid	28.16	23.24	14.05	6.26	5.26	10.08
Cash Income Tax Paid	35.32	45.05	31.53	17.09	8.83	8.92
Levered Free Cash Flow	199.78	179.41	103.13	51.35	142.07	134.36
Unlevered Free Cash Flow	210.76	192.15	111.11	54.7	144.75	140
Change in Working Capital	-20.55	-36.95	-70.02	-71.4	-17.84	34.24

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q